This inventor holds 1 USPTO granted patent. Top assignee: Millennium Pharmaceuticals Limited. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: The Innovations of Christophe Van Huffel
Introduction
Christophe Van Huffel is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of drug resistance, particularly in cancer research. His work focuses on the expression of DR6 and its implications for identifying drug-resistant cells.
Latest Patents
Christophe Van Huffel holds a patent titled "DR6 and uses thereof." This invention addresses the increased expression of DR6, which is associated with drug resistance in certain cells, including cancer cells. The patent provides methods for identifying drug-resistant cells by measuring the expression or activity of DR6. Additionally, it outlines methods for identifying modulators of drug resistance and for modulating drug resistance by influencing the expression or activity of DR6.
Career Highlights
Christophe Van Huffel is affiliated with Millennium Pharmaceuticals Limited, where he continues to advance research in drug resistance. His work has the potential to impact treatment strategies for cancer patients significantly.
Collaborations
Some of his notable coworkers include Shengfang Jin and Andrew W. Shyjan, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Christophe Van Huffel's innovative work in understanding drug resistance through the lens of DR6 expression represents a significant advancement in cancer research. His contributions are paving the way for new methods in identifying and treating drug-resistant cells.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile